Effects of vasopressin-mastoparan chimeric peptides on insulin release and G-protein activity

Regulatory Peptides

Volumn 82, Issue 1-3, 1999, Pages 45-51

  Hällbrink, Mattias ^a   Saar, Külliki ^a   Östenson, Claes Göran ^b   Soomets, Ursel ^a   Efendic, Suad ^b   Howl, John ^c,e   Wheatley, Mark ^c   Zorko, Matjaz ^a,d   Langel, Ülo ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b Endocr Diabet U Karolinska H ^*  (Sweden)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF LJUBLJANA   (Slovenia)

^e UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

Galparan; GTPase; Insulin release; Mastoparan; PTX; Vasopressin

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MASTOPARAN; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXOCYTOSIS; INSULIN RELEASE; MEMBRANE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RAT; SCINTILLATION;

ANIMALS; CELL MEMBRANE; GLUCOSE; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); INSULIN; ISLETS OF LANGERHANS; MALE; PEPTIDES; PERTUSSIS TOXIN; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, VASOPRESSIN; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED; VASOPRESSINS; VIRULENCE FACTORS, BORDETELLA; WASP VENOMS;

EID: 0345161749     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(99)00034-8     Document Type: Article

References (22)

1. Östenson C.-G., Zaitsev S., Berggren P.-G., Efendic S., Langel Ü, Bartfai T. Galparan: a powerful insulin releasing chimeric peptide acting at a novel site. Endocrinology. 138:(8):1997;3308-13.
2. Yokokawa N., Komatsu M., Takeda T., Aizawa T., Yamada T. Mastoparan, a wasp venom, stimulates insulin release by pancreatic islets through pertussis toxin sensitive GTP-binding protein. Biochem Biophys Res Commun. 158:1989;712-716.
3. Jones P.M., Mann F.M., Persaud S.J., Wheeler-Jones C.P. Mastoparan stimulates insulin secretion from pancreatic beta-cells by effects at a late stage in the secretory pathway. Mol Cell Endocrinol. 94:1993;97-103.
4. Zorko M., Pooga M., Saar K., Rezaei K., Langel Ü. Differential regulation of GTPase activity by mastoparan and galparan. Arch Biochem Biophys. 349:1998;321-328.
5. 1a vasopressin receptor binding site with pyroglutamate-substituted linear antagonists. Neuropeptides. 30:1996;73-79.
6. Longland C.L., Mezna M., Langel Ü., Hällbrink M., Soomets U., Wheatley M., Michelangeli F., Howl J. Biochemical mechanisms of calcium mobilisation induced by mastoparan and chimeric hormone-mastoparan constructs. Cell Calcium. 24:1998;27-34.
7. Tam J.P., Heath W.F., Merrifield R.B. Mechanisms for the removal of benzylprotecting groups in synthetic peptides by trifluoromethanesulfonic acid-trifluoroacetic acid-dimethylsulfide. J Am Chem Soc. 108:1985;5242-5251.
8. Langel Ü, Land T., Bartfai T. Design of chimeric peptide ligands to galanin receptors and substance P receptors. Int J Pept Protein Res. 39:1992;516-522.
9. Wheatley M., Howl J., Yarwood N.J., Davies A.R.L., Parslow R.A. Preparation of a membrane fraction for receptor studies and solubilisation of receptor proteins with retention of biological activity. Irvine G.B., Williams C.H. Methods in molecular biology. 1997;305-322 Humana Press, Totowa, USA. Neuropeptide Protocols.
10. 50) of an enzymatic reaction. Biochem Pharmacol. 22:1973;3099-3108.
11. McKenzie F.R. Basic techniques to study G-protein function. Milligan G. Signal transduction. A practical approach. 1992;31-56 Oxford University Press, Oxford.
12. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
13. Cassel D., Selinger Z. Catecholamine stimulated GTPase activity in turkey erythrocyte membranes. Biochim Biophys Acta. 452:1976;538-551.
14. Östenson C.-G., Grill V. Differences in long-term effects of L-glutamine and D-glucose on insulin release from rat pancreatic islets. Mol Cell Endocrinol. 45:1986;215-221.
15. Herbert V., Lau K.S., Gottlieb C.W., Bleicher S.J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 25:1965;1375-1384.
16. Dunning B.E., Moltz J.H., Fawcett C.P. Modulation of insulin and glucagon secretion from the perfused rat pancreas by the neurohypophysial hormones and by desamino-D-arginine vasopressin (DDAVP). Peptides. 5:1984;871-875.
17. Gao Z.Y., Drews G., Nenquin M., Plant T.D., Henquin J.C. Mechanisms of the stimulation of insulin release by arginine-vasopressin in normal mouse islets. J Biol Chem. 265:1990;15724-15730.
18. Richardson S.B., Eyler N., Twente S., Monaco M., Altszuler N., Gibson M. Effects of vasopressin on insulin secretion and inositol phosphate production in a hamster beta cell line (HIT). Endocrinology. 26:1990;1047-1052.
19. Komatsu M., Aizawa T., Yokokawa N., Sato Y., Okada N., Takasu N., Yamada T. Mastoparan-induced hormone release from rat pancreatic islets. Endocrinology. 130:1992;221-228.
20. Garcia-Sainz J.A., Macias-Silva M., Romero-Avila M.T. Effect of okadaic acid on hormone- and mastoparan-stimulated phosphoinositide turnover in isolated rat hepatocytes. Biochem Biophys Res Commun. 179:1991;852-858.
21. Eddlestone G.T., Komatsu M., Shen L.M., Sharp G.W.G. Mastoparan increases the intracellular free calcium concentration in two insulin-secreting cell lines by inhibition of ATP-sensitive potassium channels. Mol Pharmacol. 47:1995;787-797.
22. Joyce-Brady M., Rubins J.B., Panchenko M.P., Bernardo J., Steele M.P., Kolm L., Simons E.R., Dickey B.F. Mechanisms of mastoparan-stimulated surfactant secretion from isolated pulmonary alveolar type 2 cells. J Biol Chem. 266:1991;6859-6865.